Ix Biopharma Ltd. (42C)
Market Closed
14 Aug, 09:00
SGX SGX Primary S$
0. 50
-0.01
-1.9608%
S$
15.1M Market Cap
- P/E Ratio
- Div Yield
8.58M Volume
- Eps
S$ 0.51
Previous Close Want to track 42C and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ix Biopharma Ltd. (42C) Statistics
Valuation metrics
Market Cap 15.1M
Enterprise value 618.69M
Trailing P/E (ttm) -84.33
Forward P/E -
PEG ratio -1.89
Price/Sales (ttm) 109.47
Price/Book (mrq) 135.36
Enterprise Value/Revenue 109.64
Enterprise Value/EBITDA -202.72
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 26.44M
Average volume (90 days) 12.87M
Price summary
52-Week low 0.02
52-Week high 0.58
Beta -
50-Day moving average 0.42
200-Day moving average 0.32
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.85%
Operating margin -0.81%
Operational effectiveness
Return on assets -0.3%
Return on equity -2.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) 1.63
Current ratio (mrq) 1.05%
Book value per share (mrq) 0
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
